| ²é¿´: 551 | »Ø¸´: 0 | ||
xiashaoyanгæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ºÍÃÀ¹úµ¼Ê¦ÌÖÂÛÎÄÏ×ÖÐÎÊÌ⣬ÀÏʦºÜ»¶Ó£¬¸ÃÔõô»Ø¸´ÄØ£¿Çóǰ±²Ö¸½Ì
|
|
×î½üÒ»Ö±ÔÚ½¨Ä££¬¿´µ½Ò»ÆªÎÄÏ׸оõºÜºÃ£¬¾ÍÏò×÷Õßµ¼Ê¦Çó½ÌÎÄÏ×ÖеÄÎÊÌ⣬ÀÏʦºÜ»¶Ó£¬ËµÓÐʱºò¿ÉÒÔÈ¥ËûµÄµØ·½ºÍËûÒ»Æð¸üÏêϸµÄÌÖÂÛ¡£Ð¡µÜµÄÓ¢ÓïºÜÀã¬ËùÒÔÏëÇë¸÷λÓоÑéµÄÅóÓѰïæ³ö³öÖ÷Ò⣬Ôõô»Ø¸´¸øÀÏʦ£¡ ÀÏʦ»Ø¸´ÊÇ£º Hi, **, Thnak you for your interest in our work. Whether there is a linkage between a risk factor (such as plaque stress) is entirely un-settled. It is not if one has a theory. Rather, we have to provide clinical evidence to support our claims. Using critical stress has its reasons. People are using various indicators. You can certainly use something else. It is best that you discuss that with your professors. Or, you are welcome to visit US or Nanjing, whenever that is possible, for more detailed discussions. Email is very limited. Good luck! |
» ²ÂÄãϲ»¶
Ìì½òÀí¹¤´óѧ-ÐÂÄÜÔ´Ñо¿Ôº-¹ú¼Òº£ÍâÓÅÇຫ¾Ã»Û½ÌÊÚ-26Ä격ʿÕÐÉú-²ÄÁÏ¡¢»¯Ñ§µÈÁìÓò
ÒѾÓÐ1È˻ظ´
Ìì½òÀí¹¤´óѧ-ÐÂÄÜÔ´Ñо¿Ôº-¹ú¼Òº£ÍâÓÅÇຫ¾Ã»Û½ÌÊÚ-26Ä격ʿÕÐÉú-²ÄÁÏ¡¢»¯Ñ§µÈÁìÓò
ÒѾÓÐ1È˻ظ´
°ëµ¼Ìå¿ÆÑ§ÓëÐÅÏ¢Æ÷¼þÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ120È˻ظ´
085400ÊýÒ»Ó¢Ò» 354·Ö Çóµ÷¼Á ±¾¿Æ211 Ò»Ö¾Ô¸Ìì½òij985
ÒѾÓÐ1È˻ظ´
085400 354·ÖÇóµ÷¼Á Ò»Ö¾Ô¸Ìì½ò´óѧ ±¾¿Æ211
ÒѾÓÐ0È˻ظ´
΢Äɼӹ¤É豸
ÒѾÓÐ0È˻ظ´
ÉϺ£½»Í¨´óѧ¼¯³Éµç·ѧԺÄÉÃ×µç×Ӻ͹âµçÆ÷¼þÑо¿×éÕÐÊÕ²©Ê¿Éú
ÒѾÓÐ1È˻ظ´
ÉϺ£½»Í¨´óѧ¼¯³Éµç·ѧԺÄÉÃ×µç×Ӻ͹âµçÆ÷¼þÍŶÓÕÐÆ¸½ÌʦºÍ²©Ê¿ºó
ÒѾÓÐ0È˻ظ´
ÉϺ£½»Í¨´óѧ¼¯³Éµç·ѧԺÄÉÃ×µç×Ӻ͹âµçÆ÷¼þÍŶÓÕÐÊÕ²©Ê¿Éú
ÒѾÓÐ0È˻ظ´
Ìì½òÀí¹¤´óѧ-¹ú¼Òº£ÍâÓÅÇຫ¾Ã»Û½ÌÊÚ-26Ä격ʿÕÐÉú-²ÄÁÏ¡¢»¯Ñ§µÈÁìÓò
ÒѾÓÐ0È˻ظ´














»Ø¸´´ËÂ¥